查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1746874

日本生物样本库市场报告（按样本类型、生物样本库类型、应用、最终用户和地区）2025-2033

Japan Biobanking Market Report by Specimen Type, Biobank Type, Application, End User, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 119 Pages | 商品交期: 5-7个工作天内

价格
简介目录

2024年，日本生物样本库市场规模达38.03亿美元。展望未来， IMARC Group预计到2033年，该市场规模将达到56.11亿美元，2025-2033年期间的复合年增长率（CAGR）为4.4%。个人化医疗需求的不断增长，以及对生物样本和资料（用于支持研究和客製化治疗开发）的需求不断增长，共同推动着市场的发展。

生物样本库是现代医疗保健和科学研究的一个重要面向。它涉及系统地收集、储存和管理个体生物样本，例如血液、组织和DNA，以备将来用于研究、诊断和治疗开发。生物样本库在增进我们对疾病、遗传学和个人化医疗的理解方面发挥着至关重要的作用。这些储存库在严格的伦理和监管准则下保存样本及其相关资料，确保患者的隐私和知情同意。生物样本库样本是研究疾病、识别生物标记和测试新疗法的宝贵资源。它们有助于进行大规模纵向研究，揭示健康和疾病随时间推移的模式和趋势。生物样本库促进了研究人员之间的合作，加速了医学发现，并增强了根据个体基因组成製定个人化治疗方案的可能性。它还支持转化研究，弥合实验室发现与临床应用之间的差距。总而言之，生物样本库是现代医疗保健的关键基础设施，有助于推进医学知识并改善病患照护。

日本生物银行市场趋势：

日本生物样本库市场正经历强劲成长，这得益于几个关键驱动因素。首先，医学研究的进步和对个人化医疗的日益关注推动了对生物样本库服务的需求。这些生物样本库使研究人员能够获得各种各样的样本，从而加速他们了解疾病和开发标靶疗法的努力。此外，人们越来越意识到保存生物材料以供未来研究的重要性，这促使公共和私营部门增加对生物样本库基础设施的投资。此外，癌症和心血管疾病等慢性疾病的盛行率不断上升，需要建立广泛的生物样本库来支持生物标记和治疗标靶的发现。基因组医学的普及以及遗传资讯与医疗保健实践的整合进一步扩大了对生物样本库解决方案的需求。最后，监管措施和伦理考量强化了围绕生物样本库的框架，增强了利害关係人的信心并鼓励他们参与。这些相互关联的驱动因素正推动日本生物样本库市场实现前所未有的成长，并预示着未来医疗成果的改善和医学领域的突破。

日本生物银行市场细分：

样本类型洞察：

  • 血液製品
  • 实体组织
  • 细胞系
  • 核酸
  • 其他的

生物样本库类型洞察：

  • 基于人群的生物样本库
  • 以疾病为导向的生物样本库

应用程式洞察：

  • 疗法
  • 研究

最终用户洞察：

  • 学术机构
  • 製药和生物技术公司

竞争格局：

市场研究报告也对竞争格局进行了全面的分析。报告涵盖了市场结构、关键参与者定位、最佳制胜策略、竞争仪錶板和公司评估象限等竞争分析。此外，报告还提供了所有主要公司的详细资料。

本报告回答的关键问题：

  • 日本生物银行市场迄今表现如何？未来几年将如何表现？
  • COVID-19 对日本生物银行市场有何影响？
  • 根据样本类型，日本生物银行市场是如何分類的？
  • 根据生物样本库类型，日本生物样本库市场是如何分類的？
  • 日本生物银行市场根据应用如何划分？
  • 根据最终用户，日本生物银行市场是如何分類的？
  • 日本生物银行市场的价值链分为哪些阶段？
  • 日本生物银行的主要驱动因素和挑战是什么？
  • 日本生物银行市场的结构是怎么样的？主要参与者有哪些？
  • 日本生物银行市场的竞争程度如何？

本报告回答的关键问题：

  • 日本生物银行市场迄今表现如何？未来几年将如何表现？
  • COVID-19 对日本生物银行市场有何影响？
  • 根据样本类型，日本生物银行市场是如何分類的？
  • 根据生物样本库类型，日本生物样本库市场是如何分類的？
  • 日本生物银行市场根据应用如何划分？
  • 根据最终用户，日本生物银行市场是如何分類的？
  • 日本生物银行市场的价值链分为哪些阶段？
  • 日本生物银行的主要驱动因素和挑战是什么？
  • 日本生物银行市场的结构是怎么样的？主要参与者有哪些？
  • 日本生物银行市场的竞争程度如何？

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 次要来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：日本生物样本库市场－简介

  • 概述
  • 市场动态
  • 产业趋势
  • 竞争情报

第五章：日本生物样本库市场格局

  • 历史与当前市场趋势（2019-2024）
  • 市场预测（2025-2033）

第六章：日本生物样本库市场细分：依样本类型

  • 血液製品
    • 概述
  • 实体组织
    • 概述
  • 细胞系
    • 概述
  • 核酸
    • 概述
  • 其他的

第七章：日本生物样本库市场-分类：依生物样本库类型

  • 基于人群的生物样本库
    • 概述
  • 以疾病为导向的生物样本库
    • 概述

第 8 章：日本生物样本库市场 - 细分：按应用

  • 疗法
    • 概述
  • 研究
    • 概述

第九章：日本生物样本库市场-细分：按最终用户

  • 学术机构
    • 概述
  • 製药和生物技术公司
    • 概述

第十章：日本生物样本库市场－竞争格局

  • 概述
  • 市场结构
  • 市场参与者定位
  • 最佳获胜策略
  • 竞争仪錶板
  • 公司评估象限

第 11 章：关键参与者简介

  • Company A
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company B
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company C
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company D
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company E
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events

第 12 章：日本生物样本库市场 - 产业分析

  • 驱动因素、限制因素和机会
    • 概述
    • 驱动程式
    • 限制
    • 机会
  • 波特五力分析
    • 概述
    • 买家的议价能力
    • 供应商的议价能力
    • 竞争程度
    • 新进入者的威胁
    • 替代品的威胁
  • 价值链分析

第 13 章：附录

简介目录
Product Code: SR112025A18685

Japan biobanking market size reached USD 3,803 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 5,611 Million by 2033, exhibiting a growth rate (CAGR) of 4.4% during 2025-2033. The increasing demand for personalized medicine, coupled with the growing need for biological samples and data to support research and the development of tailored treatments, is driving the market.

Biobanking is a crucial aspect of modern healthcare and scientific research. It involves the systematic collection, storage, and management of biological samples, such as blood, tissue, and DNA, from individuals for future use in research, diagnostics, and treatment development. Biobanks play a vital role in advancing our understanding of diseases, genetics, and personalized medicine. These repositories preserve specimens and their associated data under strict ethical and regulatory guidelines, ensuring patient privacy and informed consent. Biobanked samples serve as valuable resources for studying diseases, identifying biomarkers, and testing new therapies. They facilitate large-scale, longitudinal studies that can uncover patterns and trends in health and disease over time. Biobanking promotes collaboration among researchers, accelerates medical discoveries, and enhances the potential for tailored treatments based on an individual's genetic makeup. It also supports translational research, bridging the gap between laboratory findings and clinical applications. In summary, biobanking is a critical infrastructure in modern healthcare, advancing medical knowledge and improving patient care.

Japan Biobanking Market Trends:

The biobanking market in Japan is experiencing robust growth due to several key drivers. Firstly, advancements in medical research and the increasing focus on personalized medicine have propelled the demand for biobanking services. These repositories of biological samples enable researchers to access a diverse range of specimens, accelerating their efforts in understanding diseases and developing targeted therapies. Moreover, the growing awareness of the importance of preserving biological materials for future research has prompted both public and private sector investments in biobanking infrastructure. In addition to this, the rising prevalence of chronic diseases, such as cancer and cardiovascular conditions, necessitates extensive biobanking to support the discovery of biomarkers and therapeutic targets. The adoption of genomic medicine and the integration of genetic information into healthcare practices have further amplified the demand for biobanking solutions. Lastly, regulatory initiatives and ethical considerations have strengthened the framework surrounding biobanking, instilling confidence among stakeholders and encouraging their participation. These interconnected drivers are propelling the biobanking market in Japan towards unprecedented growth, promising a future of improved healthcare outcomes and medical breakthroughs.

Japan Biobanking Market Segmentation:

Specimen Type Insights:

  • Blood Products
  • Solid Tissue
  • Cell Lines
  • Nucleic Acid
  • Others

Biobank Type Insights:

  • Population-based Biobanks
  • Disease-oriented Biobanks

Application Insights:

  • Therapeutics
  • Research

End User Insights:

  • Academic Institutions
  • Pharma and Biotech Companies

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

  • How has the Japan biobanking market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the Japan biobanking market?
  • What is the breakup of the Japan biobanking market on the basis of specimen type?
  • What is the breakup of the Japan biobanking market on the basis of biobank type?
  • What is the breakup of the Japan biobanking market on the basis of application?
  • What is the breakup of the Japan biobanking market on the basis of end user?
  • What are the various stages in the value chain of the Japan biobanking market?
  • What are the key driving factors and challenges in the Japan biobanking?
  • What is the structure of the Japan biobanking market and who are the key players?
  • What is the degree of competition in the Japan biobanking market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Biobanking Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Biobanking Market Landscape

  • 5.1 Historical and Current Market Trends (2019-2024)
  • 5.2 Market Forecast (2025-2033)

6 Japan Biobanking Market - Breakup by Specimen Type

  • 6.1 Blood Products
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2019-2024)
    • 6.1.3 Market Forecast (2025-2033)
  • 6.2 Solid Tissue
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2019-2024)
    • 6.2.3 Market Forecast (2025-2033)
  • 6.3 Cell Lines
    • 6.3.1 Overview
    • 6.3.2 Historical and Current Market Trends (2019-2024)
    • 6.3.3 Market Forecast (2025-2033)
  • 6.4 Nucleic Acid
    • 6.4.1 Overview
    • 6.4.2 Historical and Current Market Trends (2019-2024)
    • 6.4.3 Market Forecast (2025-2033)
  • 6.5 Others
    • 6.5.1 Historical and Current Market Trends (2019-2024)
    • 6.5.2 Market Forecast (2025-2033)

7 Japan Biobanking Market - Breakup by Biobank Type

  • 7.1 Population-based Biobanks
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2019-2024)
    • 7.1.3 Market Forecast (2025-2033)
  • 7.2 Disease-oriented Biobanks
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2019-2024)
    • 7.2.3 Market Forecast (2025-2033)

8 Japan Biobanking Market - Breakup by Application

  • 8.1 Therapeutics
    • 8.1.1 Overview
    • 8.1.2 Historical and Current Market Trends (2019-2024)
    • 8.1.3 Market Forecast (2025-2033)
  • 8.2 Research
    • 8.2.1 Overview
    • 8.2.2 Historical and Current Market Trends (2019-2024)
    • 8.2.3 Market Forecast (2025-2033)

9 Japan Biobanking Market - Breakup by End User

  • 9.1 Academic Institutions
    • 9.1.1 Overview
    • 9.1.2 Historical and Current Market Trends (2019-2024)
    • 9.1.3 Market Forecast (2025-2033)
  • 9.2 Pharma and Biotech Companies
    • 9.2.1 Overview
    • 9.2.2 Historical and Current Market Trends (2019-2024)
    • 9.2.3 Market Forecast (2025-2033)

10 Japan Biobanking Market - Competitive Landscape

  • 10.1 Overview
  • 10.2 Market Structure
  • 10.3 Market Player Positioning
  • 10.4 Top Winning Strategies
  • 10.5 Competitive Dashboard
  • 10.6 Company Evaluation Quadrant

11 Profiles of Key Players

  • 11.1 Company A
    • 11.1.1 Business Overview
    • 11.1.2 Product Portfolio
    • 11.1.3 Business Strategies
    • 11.1.4 SWOT Analysis
    • 11.1.5 Major News and Events
  • 11.2 Company B
    • 11.2.1 Business Overview
    • 11.2.2 Product Portfolio
    • 11.2.3 Business Strategies
    • 11.2.4 SWOT Analysis
    • 11.2.5 Major News and Events
  • 11.3 Company C
    • 11.3.1 Business Overview
    • 11.3.2 Product Portfolio
    • 11.3.3 Business Strategies
    • 11.3.4 SWOT Analysis
    • 11.3.5 Major News and Events
  • 11.4 Company D
    • 11.4.1 Business Overview
    • 11.4.2 Product Portfolio
    • 11.4.3 Business Strategies
    • 11.4.4 SWOT Analysis
    • 11.4.5 Major News and Events
  • 11.5 Company E
    • 11.5.1 Business Overview
    • 11.5.2 Product Portfolio
    • 11.5.3 Business Strategies
    • 11.5.4 SWOT Analysis
    • 11.5.5 Major News and Events

12 Japan Biobanking Market - Industry Analysis

  • 12.1 Drivers, Restraints, and Opportunities
    • 12.1.1 Overview
    • 12.1.2 Drivers
    • 12.1.3 Restraints
    • 12.1.4 Opportunities
  • 12.2 Porters Five Forces Analysis
    • 12.2.1 Overview
    • 12.2.2 Bargaining Power of Buyers
    • 12.2.3 Bargaining Power of Suppliers
    • 12.2.4 Degree of Competition
    • 12.2.5 Threat of New Entrants
    • 12.2.6 Threat of Substitutes
  • 12.3 Value Chain Analysis

13 Appendix